Sujata Chakraborty

Dr. Chakraborty is board certified in Clinical Cytogenetics and Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics. She joined NeoGenomics in 2018. Prior to that, she worked at Genoptix as Associate Director in Cytogenetics and Molecular Genetics for two years. Dr. Chakraborty did her doctoral research at Unilever in India and subsequently held research positions in the Genetics Department at Leiden University in the Netherlands and in the Hematopoietic Stem Cell and Leukemia Research Department at City of Hope Cancer Center in California. She has extensive research experience in DNA damage response, DNA repair and clinical cancer genetics. She is a reviewer and on the editorial board of peer-reviewed journals. Dr. Chakraborty received her fellowship training in Clinical Cytogenetics and Clinical Molecular Genetics at the department of Medical and Molecular Genetics in the Indiana University School of Medicine. She also held an academic position as an Assistant Professor and worked in multiple research projects at the University. She received the Fanconi Anemia Research Foundation Discovery Award for her contribution towards identification and characterization of a novel Fanconi anemia gene. Dr. Chakraborty holds California licenses as a Clinical Cytogeneticist Scientist and Clinical Genetic Molecular Biologist Scientist. She is a fellow of the American College of Medical Genetics and Genomics and an approved CAP inspector.